News Releases

Month Year

Email Alerts

Sep 6, 2006

Insmed to Present at the BioCentury NewsMakers in the Biotech Industry Conference
Aug 8, 2006

Insmed Incorporated Reports Financial Results for the First Half and Second Quarter Ended June 30, 2006
Aug 7, 2006

Insmed Inc. to Webcast 2006 Second Quarter Financial Results Conference Call, Tuesday, August 8, 2006 at 4:30 p.m. (ET)
Jul 31, 2006

Phyton Biotech Signs Development Agreement With Insmed
Jul 19, 2006

Insmed Inc. to Webcast 2006 Second Quarter Financial Results Conference Call, Tuesday, August 8, 2006 at 4:30 p.m. (ET)
Jul 11, 2006

Insmed to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Jul 5, 2006

European Medicines Agency Validates Insmed's Regulatory Application For Marketing IPLEX(TM) in Europe
Jul 5, 2006

Court Decision Means That Patent Dispute between Insmed and Tercica and Genentch Will Have to Be Resolved at Trial
Jun 27, 2006

Insmed Presents Positive IPLEX(TM) Data At ENDO 2006
Jun 22, 2006

Insmed Endocrine Society 2006 Update; Insmed Will Report Efficacy of IPLEX(TM) in Patients with Severe Insulin Resistance; Company Also to Present Data on the Unique Pharmacokinetics of IPLEX
Jun 13, 2006

Court Dismisses Baseless Unfair Business Practices Lawsuit That Was Brought Against Insmed
Jun 9, 2006

Insmed Provides Update on IPLEX(TM) Launch; Company Shares Details on Payer Usage Program and Pricing
May 25, 2006

INSMED Announces IPLEX(TM) Availability Nationwide for Children with Severe Short Stature; IPLEX Launch Marked By The First Product Shipments To Patients in States Across the Country
May 12, 2006

Insmed Incorporated to Present at the Rodman & Renshaw 3rd Annual Healthcare Conference
May 8, 2006

Insmed Incorporated Reports Financial Results for the First Quarter Ended March 31, 2006
May 2, 2006

Insmed Inc. to Webcast 2006 First Quarter Financial Results Conference Call, Monday May 8, 2006 at 4:30 p.m. (ET)
May 1, 2006

IPLEX(TM) Demonstrates Significant, Dose-Dependent Increases in Growth Rate
Apr 26, 2006

Insmed Announces Podium Presentation at the Pediatric Academic Societies' 2006 Annual Meeting
Apr 25, 2006

NORD Honors Insmed for Role in Developing Treatments for Rare Diseases
Mar 22, 2006

Insmed Announces Additional Information in Compliance with NASDAQ Rules
Mar 15, 2006

Insmed Completes $46 Million Public Offering; Underwriters Exercise In Full Option to Purchase Additional Shares
Mar 10, 2006

Insmed Prices $40 Million Equity Offering
Mar 6, 2006

Insmed Incorporated Announces Proposed Public Offering of Common Stock
Mar 2, 2006

Insmed Incorporated Reports Financial Results for the Fourth Quarter and Twelve-Months of 2005
Feb 23, 2006

Insmed to Announce 2005 Fourth Quarter and Year End Financial Results; Thursday, March 2
Feb 3, 2006

Insmed Incorporated Files Shelf Registration Statement
Jan 4, 2006

U. of Rochester Initiates Phase 2 Clinical Trial of Insmed's iPlex for the Treatment of Myotonic Muscular Dystrophy; Trial Funded by NIH and MDA Grants
Dec 12, 2005

FDA Approves Insmed's Orphan Drug, IPLEX, for the Treatment of Severe Primary IGF-1 Deficiency; The First Once-Daily Therapy for the Treatment of Severe Primary IFG-1 Deficiency
Dec 8, 2005

Insmed Responds to Complaint Filed by Tercica
Nov 28, 2005

Insmed to Present at the Lazard Capital Markets Life Sciences Conference
Nov 5, 2005

Insmed Incorporated Reports Financial Results for the Third Quarter and First Nine Months of 2005
Nov 2, 2005

Insmed to Present at the Rodman and Renshaw 7th Annual Healthcare Conference
Nov 1, 2005

Insmed to Release Third Quarter Financial Results; Thursday, November 3
Oct 25, 2005

Insmed Receives European Orphan Drug Designation for SomatoKine for the Treatment of Extreme Insulin Resistance; Company to Initiate Clinial Trial in Type A Insulin Resistance
Oct 25, 2005

FDA to Review Insmed's Complete Response to Approvable Letter for iPlex
Oct 24, 2005

Insmed to Present at the C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference
Oct 18, 2005

Insmed to Present at the BIO Investor Forum Conference
Oct 17, 2005

Insmed Submits Response to FDA Approvable Letter for iPlex
Sep 29, 2005

Insmed Issues Statement Regarding IPLEX(TM) Approvable Letter Press Release
Sep 29, 2005

Insmed Provides Update on iPlex Pivotal Trial Data in Severe Primary IGF-1 Deficiency
Sep 25, 2005

Insmed Receives Approvable Letter for iPlex(TM); Conference Call Tomorrow at 8:00am EST
Sep 24, 2005

Insmed Announces Appointment of Dr. Kenneth Attie; Former Genentech Researcher Assumes Role as Medical Director
Sep 19, 2005

SomatoKine(R) Pivotal Data to Be Featured in a Podium Presentation at the ESPE/LWPES 7th Joint Meeting of Pediatric Endocriniology in Lyon, France
Aug 8, 2005

Insmed Incorporated Reports Financial Results for the Second Quarter and First Half of 2005
Aug 2, 2005

Insmed to Release Second Quarter Financial Results; Monday, August 8
Jun 10, 2005

FDA Extends PDUFA Date for SomatoKine to October 03, 2005
May 31, 2005

Insmed Reports Detailed Positive Results from Its Pivotal Clinical Trial of SomatoKine in Patients with Growth Hormone Insensitivity Syndrome
May 25, 2005

Insmed to Present at Needham & Company Biotechnology Conference May 26, 2005
May 24, 2005

Insmed Announces the Continuation of Litigation in the United Kingdom; Judge's Ruling Allows for the Continuation of Legal Action in Suit Filed by Tercica
May 19, 2005

Insmed to Present at UBS Global Pharmaceutical Conference May 23, 2005

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

View the latest Insmed Investor Presentation

Download

Our Global Company

Current Clinical Trials

Our Research Team

Our Global Company

Current Clinical Trials

Our Research Team

Footer